.post-body img { max-width:400px; max-height:auto; }

Sunday, August 29, 2021

The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro



Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment.

ORIGINAL LINK